首页> 外文OA文献 >A 3-month, Multicenter, Randomized, Open-label Study to Evaluate the Impact on Wound Healing of the Early (vs Delayed) Introduction of Everolimus in De Novo Kidney Transplant Recipients, With a Follow-up Evaluation at 12 Months After Transplant (NEVERWOUND Study)

【2h】

A 3-month, Multicenter, Randomized, Open-label Study to Evaluate the Impact on Wound Healing of the Early (vs Delayed) Introduction of Everolimus in De Novo Kidney Transplant Recipients, With a Follow-up Evaluation at 12 Months After Transplant (NEVERWOUND Study)

机译：3个月，多中心，随机，开放标签研究，评估对德诺肾移植受者的早期（延迟）血液血症的伤口愈合的影响，移植后12个月后的后续评估（从未使用过学习）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Tommaso Maria Manzia; Mario Carmellini; Paola Todeschini; Antonio Secchi; Silvio Sandrini; Enrico Minetti; Lucrezia Furian; Gionata Spagnoletti; Francesco Pisani; Gian Benedetto Piredda; Gianni Cappelli; GIuseppe Tisone;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. A 3-month, Multicenter, Randomized, Open-label Study to Evaluate the Impact on Wound Healing of the Early (vs Delayed) Introduction of Everolimus in De Novo Kidney Transplant Recipients, With a Follow-up Evaluation at 12 Months After Transplant (NEVERWOUND Study) [J] . Transplantation: Official Journal of the Transplantation Society . 2020,第2期

机译：3个月，多中心，随机，开放标签研究，评估对德诺肾移植受者的早期（延迟）血液血症的伤口愈合的影响，移植后12个月后的后续评估（从未使用过学习）
2. Erratum: Efficacy and safety of de novo or early everolimus with low cyclosporine in deceased-donor kidney transplant recipients at specified risk of delayed graft function: 12-month results of a randomized, multicenter trial (Transplant International (2010) 23 (1084-1093) DOI: 10.1111/j.1432-2277.2010. 01094.x) [J] . DantalJ., BerthouxF., MoalM.-C., Transplant international : . 2012,第1期

机译：勘误：具有特定的延迟移植功能风险的已故供者肾移植受者从头开始或早期环孢霉素低的依维莫司的疗效和安全性：一项随机，多中心试验的12个月结果（Transplant International（2010）23（1084-1093））DOI：10.1111 / j.1432-2277.2010。01094.x）
3. Efficacy and safety of de novo or early everolimus with low cyclosporine in deceased-donor kidney transplant recipients at specified risk of delayed graft function: 12-month results of a randomized, multicenter trial. [J] . Dantal J, Berthoux F, Moal MC, Transplant international : . 2010,第11期

机译：从头开始或早期依维莫司低环孢菌素在已故供肾延迟移植风险中的死者肾移植受者的疗效和安全性：一项随机，多中心试验的12个月结果。
4. Evaluation of the Bioequivalence of the 20 mg /10 ml Doses of Two Injectable Preparations of Eptifibatide: A Randomized, Open-Label, Two-Period Crossover Study in Healthy Adult Male Chinese Volunteers [C] . Yanhui Gao, Baoqiu Li, Jun Sun Chinese international peptide symposium . 2011

机译：评价20mg / 10ml的两种可注射制剂的20mg / 10ml剂量的两种可注射制剂：在健康成年男性志愿者中随机，开放标签，双周交叉研究
5. Identifying factors associated with participation in research studies among kidney transplant recipients [D] . Singh, Maninder K. 2011

机译：确定与肾移植受者参与研究相关的因素
6. Design and rationale of the ATHENA study – A 12-month multicentre prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial [O] . Claudia Sommerer, Barbara Suwelack, Duska Dragun, 2016

机译：ATHENA研究的设计和基本原理–一项为期12个月的多中心前瞻性研究评估了从头进行依维莫司治疗与环孢素或他克莫司减量相较于标准方案在肾移植患者中的治疗效果：随机对照研究方案试用
7. Efficacy and safety of de novo or early everolimus with low cyclosporine in deceased-donor kidney transplant recipients at specified risk of delayed graft function: 12-month results of a randomized, multicenter trial [O] . Jacques Dantal, François Berthoux, Marie-Christine Moal, 2010

机译：De novo或早期everolimus的疗效和安全性在死亡者肾移植受者中具有低环孢菌素的延迟接枝功能的风险：随机，多中心试验的12个月结果

A 3-month, Multicenter, Randomized, Open-label Study to Evaluate the Impact on Wound Healing of the Early (vs Delayed) Introduction of Everolimus in De Novo Kidney Transplant Recipients, With a Follow-up Evaluation at 12 Months After Transplant (NEVERWOUND Study)

著录项

相似文献

相关主题

期刊订阅